Pansend Life Sciences

MediBeacon is an optical diagnostics company developing real-time organ function monitoring solutions. Its portfolio focuses on fluorescent tracer-agent systems that enable continuous assessment of kidney function, including the NIC-Kidney device for monitoring glomerular filtration rate in preclinical settings and a renal function system that pairs an optical skin sensor with a proprietary light-activated agent to provide continuous real-time kidney monitoring in clinical environments. The company also maintains a pipeline of light-activated agents for physiological monitoring, surgical guidance and imaging. By commercializing biocompatible optical agents, MediBeacon aims to support critical care and surgical decision-making, enhancing dosing accuracy and patient outcomes in ICUs and operating suites. The technology supports monitoring of kidney and other vital organ functions, helping clinicians intervene in a timely manner.